Petr Karásek

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

J-Y Douillard, David Cunningham, AD Roth et al. · The Lancet · 2000 · 3.3K citations

Medicine, Pharmacology, Colorectal Cancer +6

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

Eric Van Cutsem, Helgi van de Velde, Petr Karásek et al. · Journal of Clinical Oncology · 2004 · 772 citations · Full text

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

Philippe Rougier, Hanno Riess, Robert Manges et al. · European Journal of Cancer · 2013 · 179 citations

Oncology, Pancreatic Cancer, Pharmacology +6

Lipidomic profiling of human serum enables detection of pancreatic cancer

Denise Wolrab, Robert Jirásko, Eva Cífková et al. · Nature Communications · 2022 · 162 citations · Full text

MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma

Petra Vychytilova‐Faltejskova, Igor Kišš, Sona Klusova et al. · Diagnostic Pathology · 2015 · 72 citations · Full text